skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

The ubiquitin–proteasome system as a molecular target in solid tumors: an update on bortezomib

Review

(2596) Views  (710) Full article downloads

Authors: A Milano, F Perri, F Caponigro

Published Date June 2009 Volume 2009:2 Pages 171 - 178
DOI: http://dx.doi.org/10.2147/OTT.S4503

A Milano,1 F Perri,2 F Caponigro2

1Sandro Pitigliani Medical Oncology Unit, Department of Oncology, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy; 2Head and Neck Medical Oncology Unit, National Tumour institute of Naples, Naples, Italy

Abstract: The ubiquitin–proteasome system has become a promising molecular target in cancer therapy due to its critical role in cellular protein degradation, interaction with cell cycle and apoptosis regulation, and unique mechanism of action. Bortezomib (PS-341) is a potent and specific reversible proteasome inhibitor, which has shown strong in vitro antitumor activity as single agent and in combination with other cytotoxic drugs in a broad spectrum of hematological and solid malignancies. In preclinical studies, bortezomib induced apoptosis of malignant cells through the inhibition of NF-κB and stabilization of pro-apoptotic proteins. Bortezomib also promotes chemo- and radiosensitization of malignant cells in vitro and inhibits tumor growth in murine xenograft models. The proteasome has been established as a relevant target in hematologic malignancies and bortezomib has been approved for the treatment of multiple myeloma. This review summarizes recent data from clinical trials in solid tumors.

Keywords: proteasome, bortezomib, NF-κB, clinical studies, solid tumors






 

Other articles by Dr Francesco Caponigro



Readers of this article also read:

Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection
Management of glucocorticoids-induced osteoporosis: role of teriparatide
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Multiple roles and therapeutic implications of Akt signaling in cancer
Coenzyme Q10 effects in neurodegenerative disease
Antibiotic treatment of exacerbations of COPD in general practice: long-term impact on healthrelated quality of life
The dual kinase complex FAK-Src as a promising therapeutic target in cancer
An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease
Development and implementation of treadmill exercise testing protocols in COPD
Phenotype characterization of embryoid body structures generated by a crystal comet effect tail in an intercellular cancer collision scenario